Michael Hughes

7.8k total citations · 3 hit papers
187 papers, 3.5k citations indexed

About

Michael Hughes is a scholar working on Pathology and Forensic Medicine, Dermatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael Hughes has authored 187 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Pathology and Forensic Medicine, 72 papers in Dermatology and 38 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Hughes's work include Systemic Sclerosis and Related Diseases (118 papers), Dermatologic Treatments and Research (64 papers) and Mast cells and histamine (30 papers). Michael Hughes is often cited by papers focused on Systemic Sclerosis and Related Diseases (118 papers), Dermatologic Treatments and Research (64 papers) and Mast cells and histamine (30 papers). Michael Hughes collaborates with scholars based in United Kingdom, United States and Italy. Michael Hughes's co-authors include Ariane L. Herrick, John D Pauling, Vivienne I. Rebel, Fiona L. Watson, Masahiro Kondo, Franziska Thomas, David L. Lamar, Dietmar Schmucker, Marco Matucci‐Cerinic and Christopher P. Denton and has published in prestigious journals such as Science, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Michael Hughes

176 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Extensive Diversity of Ig-Superfamily Proteins in the Immune System of Insects

2005 522 citations Fiona L. Watson, Franziska Thomas et al. Science profile →
Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis

2014 421 citations Michael Hughes et al. profile →
Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows

2024 37 citations Francesco Salton, Paola Confalonieri et al. Pharmaceuticals profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Hughes United Kingdom	28	1.6k	989	929	512	452	187	3.5k
Sung Eun Chang South Korea	33	582 0.4×	474 0.5×	2.4k 2.6×	208 0.4×	557 1.2×	353	5.4k
Elizabeth Lazaridou Greece	27	306 0.2×	517 0.5×	1.2k 1.3×	127 0.2×	173 0.4×	132	2.6k
Clay J. Cockerell United States	39	685 0.4×	336 0.3×	1.9k 2.0×	415 0.8×	398 0.9×	277	5.4k
Pierre‐Antoine Gourraud France	38	1.2k 0.7×	2.1k 2.1×	392 0.4×	204 0.4×	280 0.6×	163	4.9k
A. Neil Crowson United States	43	1.4k 0.9×	632 0.6×	2.6k 2.8×	456 0.9×	361 0.8×	148	5.4k
Anthony J. Mancini United States	43	1.6k 1.0×	320 0.3×	1.4k 1.5×	302 0.6×	3.4k 7.4×	154	6.5k
Bruce R. Smoller United States	47	1.5k 1.0×	695 0.7×	3.2k 3.5×	566 1.1×	985 2.2×	337	7.4k
E Grosshans France	36	751 0.5×	675 0.7×	2.0k 2.2×	293 0.6×	382 0.8×	303	4.8k
Zoé Apalla Greece	36	499 0.3×	404 0.4×	2.3k 2.4×	394 0.8×	257 0.6×	205	4.8k
Steven E. Wilson United States	78	218 0.1×	582 0.6×	418 0.4×	481 0.9×	595 1.3×	327	18.7k

Countries citing papers authored by Michael Hughes

Since Specialization

Citations

This map shows the geographic impact of Michael Hughes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hughes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hughes more than expected).

Fields of papers citing papers by Michael Hughes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Hughes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hughes. The network helps show where Michael Hughes may publish in the future.

Co-authorship network of co-authors of Michael Hughes

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Hughes. A scholar is included among the top collaborators of Michael Hughes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Hughes. Michael Hughes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Salton, Francesco, et al.. (2025). The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis. Pharmaceuticals. 18(3). 411–411. 1 indexed citations

Hughes, Michael, Barbara Ruaro, Zsuzsanna H. McMahan, et al.. (2025). Raynaud’s phenomenon is associated with an increased risk of cardiovascular disease and venous thromboembolism. Seminars in Arthritis and Rheumatism. 74. 152799–152799.

Castaldo, Nadia, Vincenzo Patruno, Michael Hughes, et al.. (2025). Retrospective Observational Study of Nintedanib in Managing Idiopathic and Progressive Pulmonary Fibrosis in Routine Practice. Journal of Clinical Medicine. 14(18). 6665–6665. 1 indexed citations

Castillo, Alfredo, Carmen Pilar Simeón‐Aznar, Elizabeth Barba, et al.. (2025). The role of prokinetics in managing gastrointestinal involvement in SSc: a systematic literature review. Lara D. Veeken. 64(6). 3266–3279. 1 indexed citations

Murray, Helen Burton, Alfredo Castillo, Carolina Malagelada, et al.. (2025). Avoidant or Restrictive Food Intake Disorder Symptoms in Adults With Systemic Sclerosis: A Nationwide Study in Spain. Arthritis Care & Research. 77(11). 1374–1383. 1 indexed citations

Güler, Aslıhan Avanoğlu, Corrado Campochiaro, Giacomo De Luca, et al.. (2024). Calcinosis in systemic sclerosis: An update on pathogenesis, related complications, and management: A heavy burden still waiting to be lifted off patients’ hands. Seminars in Arthritis and Rheumatism. 66. 152431–152431. 3 indexed citations

Donato, Stefano Di, Suiyuan Huang, John D Pauling, et al.. (2024). Clinically relevant differences between primary Raynaud's phenomenon and secondary to connective tissue disease. Seminars in Arthritis and Rheumatism. 68. 152521–152521. 3 indexed citations

Confalonieri, Paola, Francesco Salton, Metka Kodric, et al.. (2024). Safety of Nintedanib in a Patient with Chronic Pulmonary Fibrosis and Kidney Disease. Pharmaceuticals. 17(9). 1147–1147. 4 indexed citations

Spierings, Julia, Paco M J Welsing, Francesco Del Galdo, et al.. (2024). Self-reported skin severity and quality of life in systemic sclerosis: multicentre validation of PASTUL. Lara D. Veeken. 64(5). 2802–2809.

10.

Hughes, Michael, Giulia Bandini, Zsuzsanna H. McMahan, et al.. (2024). Gastrointestinal Manifestations of Sarcoidosis: A State-of-the-Art, Comprehensive Review of the Literature—Practical Clinical Insights and Many Unmet Needs on Diagnosis and Treatment. Pharmaceuticals. 17(9). 1106–1106. 3 indexed citations

11.

Salton, Francesco, et al.. (2024). Vascular Endothelial Damage in COPD: Where Are We Now, Where Will We Go?. Diagnostics. 14(9). 950–950. 4 indexed citations

12.

Bandini, Giulia, Alessia Alunno, Corrado Campochiaro, et al.. (2023). A Multinational Survey Investigating the Unmet Needs and Patient Perspectives Concerning Proton Pump Inhibitors in Systemic Sclerosis . Arthritis Care & Research. 76(5). 608–615. 4 indexed citations

13.

Maggio, Giuseppe, Paola Confalonieri, Francesco Salton, et al.. (2023). Biomarkers in Systemic Sclerosis: An Overview. Current Issues in Molecular Biology. 45(10). 7775–7802. 13 indexed citations

14.

Confalonieri, Paola, Riccardo Pozzan, Michael Hughes, et al.. (2023). Microvascular Alteration in COVID-19 Documented by Nailfold Capillaroscopy. Diagnostics. 13(11). 1905–1905. 8 indexed citations

15.

Ruaro, Barbara, Francesco Salton, Elisa Baratella, et al.. (2022). An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients. Diagnostics. 12(3). 616–616. 21 indexed citations

16.

Hughes, Michael, Steven K. Rogers, Tonia Moore, et al.. (2020). Imaging digital arteries in systemic sclerosis by tomographic 3-dimensional ultrasound. Rheumatology International. 41(6). 1089–1096. 5 indexed citations

17.

Hughes, Michael, et al.. (2019). Raynaud's phenomenon. British Journal of Hospital Medicine. 80(11). 658–664. 23 indexed citations

18.

Hughes, Michael & Ariane L. Herrick. (2019). Systemic sclerosis. British Journal of Hospital Medicine. 80(9). 530–536. 87 indexed citations

19.

Hughes, Michael & Ariane L. Herrick. (2012). System sclerosis. British Journal of Hospital Medicine. 73(9). 509–516. 4 indexed citations

20.

Watson, Fiona L., Franziska Thomas, David L. Lamar, et al.. (2005). Extensive Diversity of Ig-Superfamily Proteins in the Immune System of Insects. Science. 309(5742). 1874–1878. 522 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact